Sumitomo Mitsui Trust Holdings, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,542,002 shares of DNA stock, worth $20.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,542,002
Previous 55,865,048
95.45%
Holding current value
$20.6 Million
Previous $64.8 Million
98.71%
% of portfolio
0.0%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding DNA
# of Institutions
346Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.16 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.12 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.09 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$565 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$340 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.4B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...